Status: Recruiting
[KJ-TFC-005] Phase 3 Study, Evaluate the Efficacy and Safety of TFC-003 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
\[KJ-TFC-005\] Phase 3 Study, Evaluate the Efficacy and Safety of TFC-003 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
Participants needed: 188
Trial details
Phase: Phase 3Age: 19+Biological sex: AllType: InterventionalSponsor: Kukje PharmaUpdated: Jun 23, 2026Locations: 1
Eligibility criteria
Male or female adults aged ≥19 years at the time of informed consent. [+8]
Central visual field defect with mean deviation (MD) ≤ -25 dB on visual field te... [+19]